Exhaled nitric oxide and exhaled breath condensate pH in severe refractory asthma

Chest

Volumn 138, Issue 1, 2010, Pages 107-113

  Tseliou, Eleni ^a   Bessa, Vasiliki ^a   Hillas, Georgios ^b   Delimpoura, Vasiliki ^a   Papadaki, Georgia ^a   Roussos, Charis ^a   Papiris, Spyros ^a   Bakakos, Petros ^a   Loukides, Stelios ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b SOTIRIA GENERAL HOSPITAL   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; ASTHMA; BREATH ANALYSIS; CELL COUNT; CONTROLLED STUDY; EOSINOPHILIA; EXHALED BREATH CONDENSATE PH; FEMALE; FRACTIONAL EXHALED NITRIC OXIDE; HUMAN; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; NEUTROPHILIA; PATIENT; PH MEASUREMENT; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; SEVERE REFRACTORY ASTHMA; SPUTUM ANALYSIS;

EID: 77954740897     PISSN: 00123692     EISSN: 19313543     Source Type: Journal    
DOI: 10.1378/chest.09-1257     Document Type: Article

References (33)

1. Bateman ED, Hurd SS, Barnes PJ, et al. Global strategy for asthma management and prevention:GINA executive summary. Eur Respir J. 2008;31:143-178.
2. American Thoracic Society. Proceedings of the ATS Workshop on Refractory Asthma. Current understanding, recommendation, and unanswered questions. Am J Respir Critical Care Med. 2000;162:2341-2351.
3. Holgate ST, Polosa R. The mechanisms, diagnosis, and management of severe asthma in adults. Lancet. 2006;368(9537): 780-793.
4. Chanez P, Wenzel SE, Anderson GP, et al. Severe asthma in adults: what are the important questions? J Allergy Clin Immunol. 2007;119(6):1337-1348.
5. Gustafsson LE, Leone AM, Persson MG, Wiklund NP, Moncada S. Endogenous nitric oxide is present in the exhaled air of rabbits, guinea pigs and humans. Biochem Biophys Res Commun. 1991;181(2):852-857.
6. Kharitonov SA, Yates D, Robbins RA, Logan-Sinclair R, Shinebourne EA, Barnes PJ. Increased nitric oxide in exhaled air of asthmatic patients. Lancet. 1994;343(8890):133-135.
7. Kharitonov SA, Barnes PJ. Exhaled markers of pulmonary disease . Am J Respir Crit Care Med. 2001;163(7):1693-1722.
8. Smith AD, Cowan JO, Brassett KP, Herbison GP, Taylor DR. Use of exhaled nitric oxide measurements to guide treatment in chronic asthma. N Engl J Med. 2005;352(21):2163-2173.
9. Shaw DE, Berry MA, Thomas M, et al. The use of exhaled nitric oxide to guide asthma management:a randomized controlled trial. Am J Respir Crit Care Med. 2007;176(3):231-237.
10. Brightling CE. Clinical applications of induced sputum. Chest. 2006;129(5):1344-1348.
11. Green RH, Brightling CE, McKenna S, et al. Asthma exacerbations and sputum eosinophil counts:a randomised controlled trial. Lancet. 2002;360(9347):1715-1721. (Pubitemid 35447900)
12. Lemière C, Ernst P, Olivenstein R, et al. Airway inflammation assessed by invasive and noninvasive means in severe asthma: eosinophilic and noneosinophilic phenotypes. J Allergy Clin Immunol. 2006;118(5):1033-1039. (Pubitemid 44666987)
13. Horváth I, Hunt J, Barnes PJ, et al;ATS/ERS Task Force on Exhaled Breath Condensate. Exhaled breath condensate: methodological recommendations and unresolved questions. Eur Respir J. 2005;26(3):523-548.
14. Paget-Brown AO, Ngamtrakulpanit L, Smith A, et al. Normative data for pH for exhaled breath condensate. Chest. 2006;126(2):426-430. (Pubitemid 43289865)
15. Kostikas K, Papatheodorou G, Ganas K, Psathakis K, Panagou P, Loukides S. pH in expired breath condensate of patients with inflammatory airway diseases. Am J Respir Crit Care Med. 2002;165(10):1364-1370. (Pubitemid 34522938)
16. Global Strategy for Asthma Management and Prevention. Bethesda, MD:National Institutes of Health, National Heart, Lung, and Blood Institute;2005. NIH publication 02-3659, updated.
17. American Thoracic Society; European Respiratory Society. ATS/ERS recommendations for standardized procedures for the online and offline measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide, 2005. Am J Respir Crit Care Med. 2005;171(8):912-930.
18. Menzies D, Nair A, Lipworth BJ. Portable exhaled nitric oxide measurement: Comparison with the "gold standard"technique. Chest. 2007;131(2):410-414.
19. Kips JC, Fahy JV, Hargreave FE, Ind PW, in't Veen JC. Methods for sputum induction and analysis of induced sputum: a method for assessing airway inflammation in asthma. Eur Respir J Suppl. 1998;26 :9S-12S.
20. Grootendorst DC, van den Bos JW, Romeijn JJ, et al. Induced sputum in adolescents with severe stable asthma. Safety and the relationship of cell counts and eosinophil cationic protein to clinical severity. Eur Respir J. 1999;13(3):647-653.
21. Efthimiadis A, Spanevello A, Hamid Q, et al. Methods of sputum processing for cell counts, immunocytochemistry and in situ hybridisation. Eur Respir J. 2002;20:19S-23S.
22. Spanevello A, Confalonieri M, Sulotto F, et al. Induced sputum cellularity. Reference values and distribution in normal volunteers. Am J Respir Crit Care Med. 2000;162(3 Pt 1): 1172-1174.
23. Jatakanon A, Uasuf C, Maziak W, Lim S, Chung KF, Barnes PJ. Neutrophilic inflammation in severe persistent asthma. Am J Respir Crit Care Med. 1999;160(5 Pt 1):1532-1539.
24. Louis R, Lau LC, Bron AO, Roldaan AC, Radermecker M, Djukanovi? R. The relationship between airways inflammation and asthma severity. Am J Respir Crit Care Med. 2000; 161(1):9-16. (Pubitemid 30055896)
25. American Thoracic Society. Standardization of spirometry: 1994 update. Am J Respir Crit Care Med. 1995;152(3): 1107-1136.
26. American Thoracic Society. Guidelines for methacholine and exercise challenge testing - 1999. Am J Respir Crit Care Med. 2000;161(1):309-329.
27. Silkoff PE, Lent AM, Busacker AA, et al. Exhaled nitric oxide identifies the persistent eosinophilic phenotype in severe refractory asthma. J Allergy Clin Immunol. 2005;116(6): 1249-1255.
28. Newton R. Molecular mechanisms of glucocorticoid action: what is important? Thorax. 2000;55(7):603-613.
29. Jones KL, Bryan TW, Jinkins PA, et al. Superoxide released from neutrophils causes a reduction in nitric oxide gas. Am J Physiol. 1998;275(6 Pt 1):1120-1126.
30. van Veen IH, Ten Brinke A, Sterk PJ, et al. Exhaled nitric oxide predicts lung function decline in difficult-to-treat asthma. Eur Respir J. 2008;32(2):344-349.
31. Montuschi P, Corradi M, Ciabattoni G, Nightingale J, Kharitonov SA, Barnes PJ. Increased 8-isoprostane, a marker of oxidative stress, in exhaled condensate of asthma patients. Am J Respir Crit Care Med. 1999;160(1):216-220. (Pubitemid 29326091)
32. Thomas RA, Green RH, Brightling CE, et al. The influence of age on induced sputum differential cell counts in normal subjects. Chest. 2004;126(6):1811-1814.
33. Belda J, Leigh R, Parameswaran K, O'Byrne PM, Sears MR, Hargreave FE. Induced sputum cell counts in healthy adults. Am J Respir Crit Care Med. 2000;161(2 Pt 1):475-478. (Pubitemid 30129455)